• 1
    Steffen R, Sack DA, Riopel L et al. Therapy of travelers' diarrhea with rifaximin on various continents. Am J Gastroenterol 2003; 98: 10731078.DOI: 10.1016/S0002-9270(02)06005-7
    Direct Link:
  • 2
    Murray BE, Rensimer ER, DuPont HL. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim/sulfamethoxazole. N Engl J Med 1982; 306: 130135.
  • 3
    Gomi H, Jiang Z-D, Adachi JA et al. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother 2001; 45: 212216.DOI: 10.1128/AAC.45.1.212-216.2001
  • 4
    Thornsberry C, Hill BC, Swenson JM, McDougal LK. Rifampin: spectrum of antibacterial activity. Rev Infect Dis 1983; 5(suppl 3): S412S417.
  • 5
    Farr BM. Rifamycins. In: MandellGL, BennettJE, DolinR, eds. Principles and practice of infectious diseases, 5th edn. Philadelphia: Churchill Livingstone, 2000; 348361.
  • 6
    Hoover W, Gerlach E, Hoban D, Eliopoulos G, Pfaller M, Jones R. Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative. Diagn Microbiol Infect Dis 1993; 16: 111118.DOI: 10.1016/0732-8893(93)90004-Q
  • 7
    Gillis J, Brogden R. Rifaximin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs 1995; 49: 467484.
  • 8
    Corazza GR, Ventrucci M, Strocchi A et al. Treatment of small intestine bacterial overgrowth with rifaximin, a non-absorbable rifamycin. J Int Med Res 1988; 16: 312316.
  • 9
    Miglio F, Valpiani D, Ricca Rossellini S, Ferrieri A. Rifaximin, a nonabsorbable rifamycin, for the treatment of hepatic encephalopathy: a double-blind randomized trial. Curr Med Res Opin 1997; 13: 593601.
  • 10
    Beseghi U, De'Angelis GL. Comparison of two non-absorbable antibiotics for treatment of bacterial enteritis in children. Eur Rev Med Pharmacol Sci 1997; 2: 131136.
  • 11
    Soro O, Pesce A, Raggi M, Debbia EA, Schito GC. Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin. Clin Microbiol Infect 1997; 3: 147151.
  • 12
    DuPont HL, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med 1993; 328: 18211827.DOI: 10.1056/NEJM199306243282507